Nasal Sprays: Why Experts Say They Could Beat COVID-19 Vaccines

COVID-19 vaccines have saved millions of lives and remain one of the most important public health tools ever developed. But some experts believe nasal sprays could eventually outperform traditional COVID-19 vaccines in key ways—especially for stopping infection before it starts.

That does not mean nasal sprays are already better than vaccines overall, or that people should replace vaccination with a spray. Instead, the idea is that a nasal COVID vaccine or nasal spray-based immune treatment may offer stronger protection in the nose and upper airways, where the virus first enters the body.

This article explains why experts are interested in nasal sprays, what “beat” really means in this context, how they could work, and what the current limitations are.

The short answer: why nasal sprays matter

Experts are excited about nasal sprays because COVID-19 usually begins in the nose and throat. Traditional vaccines are excellent at reducing severe disease, hospitalization, and death, but they are less effective at fully stopping the virus from taking hold in the upper respiratory tract.

A nasal spray could potentially:

• create immunity directly in the nose
• block the virus earlier
• reduce infection and transmission
• be easier to use than injections
• improve vaccine acceptance for some people

So when experts say nasal sprays could “beat” COVID-19 vaccines, they usually mean they may be better at preventing infection and spread, not necessarily better at preventing severe illness in every case.

That distinction matters because the best public health tool is not always the one that sounds strongest in theory. It is the one that protects people in the ways that matter most and can actually be used widely. For that reason, many researchers are looking at nasal delivery as a practical upgrade rather than a total replacement.

For readers interested in how respiratory illnesses affect the upper airway more broadly, Shams Mag also covers Bronchitis in Winter: Symptoms, Causes & Relief Tips, which is another helpful example of why the nose, throat, and lungs are such important infection sites.

Why current COVID-19 vaccines are still important

Before looking at nasal sprays, it helps to understand what current COVID-19 vaccines do well.

Injected vaccines train the immune system to recognize the coronavirus and respond quickly. They have been highly effective at:

• lowering the risk of severe COVID-19
• reducing hospitalizations
• preventing death
• helping protect vulnerable people

However, injectable vaccines mainly produce strong systemic immunity, which means protection throughout the body. They do not always produce equally strong mucosal immunity in the nose and upper airways.

That matters because the nose is where the virus often first enters and begins replicating.

In practice, this means a person can still become infected even if they are well protected against severe illness. They may have fewer symptoms or recover faster, but the initial infection can still happen in the upper airway. A nasal vaccine is attractive precisely because it aims to close that gap.

To understand how infection enters the body and why local symptoms can appear early, it can also help to read about Blood When Blowing Nose: Causes and When to Worry, which discusses how delicate the nasal passages can be when they are irritated or inflamed.

What is mucosal immunity?

Mucosal immunity is the immune protection that acts on the moist surfaces of the body, such as the:

• nose
• mouth
• throat
• lungs
• gut

These surfaces are the first line of defense against many infections.

A nasal spray vaccine is designed to stimulate this local defense system, especially in the upper respiratory tract. The goal is to stop the virus before it gains a foothold.

This is one reason experts are interested in nasal vaccines for COVID-19: they may help prevent a person from becoming infected in the first place, rather than only reducing how sick they become after infection.

Mucosal immunity is not a new idea. Scientists have studied it for years in the context of influenza, RSV, and other respiratory infections. The reason it keeps coming up is simple: if a virus enters through a mucosal surface, a local immune response can sometimes intercept it earlier than a body-wide response can.

How a nasal COVID vaccine could work

A nasal vaccine is delivered through the nose rather than by needle. It exposes the immune system in the nasal passages to a viral target, which helps the body create antibodies and immune memory right at the point of entry.

In theory, this could:

1. Neutralize the virus in the nose
2. Reduce viral replication early
3. Lower the chance of transmission to others
4. Provide a broader barrier against respiratory infection

Some nasal vaccine approaches use viral vectors, protein subunits, or live-attenuated platforms. Others are being studied as boosters following injectable vaccines.

The big advantage is location: the immune response is generated where the virus first attacks.

That does not guarantee complete protection, but it may give the immune system a head start. If a virus can be slowed or neutralized before it spreads deeper into the airways, the resulting infection may be less likely to become contagious or severe.

Why experts think nasal sprays may outperform shot-based vaccines in some ways

Experts are not usually saying that nasal sprays are universally superior. They are saying that nasal delivery may solve a major weakness of current vaccines: limited upper-airway protection.

Here are the main reasons nasal sprays could be better in specific areas.

1. Better protection against infection, not just severe disease

Injected vaccines are very good at preventing severe outcomes, but the virus can still sometimes infect the nose and throat before the immune system fully responds.

A nasal spray may create a faster local response that blocks infection earlier.

That could mean:

• fewer breakthrough infections
• fewer mild or moderate cases
• reduced spread in households, schools, and workplaces

This is especially important for crowded indoor environments where respiratory viruses spread quickly. If a nasal approach can reduce the amount of virus that takes hold, it may reduce the size and duration of outbreaks.

2. Stronger reduction in transmission

If a person is infected but has enough local nasal immunity to reduce viral replication, they may be less likely to pass the virus to others.

This is one of the most appealing possibilities for public health. A vaccine that protects both the individual and the community would be a major advance.

Transmission reduction is one of the reasons researchers are paying attention to next-generation delivery methods. Many people already accept that vaccines can keep them out of the hospital; what public health officials want even more is a tool that also helps slow spread at the population level.

3. Easier and less intimidating for some people

Needle-free delivery is a big deal.

Nasal Sprays may be preferred by:

• children
• people with needle anxiety
• individuals who avoid injections
• communities with lower vaccine uptake due to delivery concerns

If a nasal spray increases participation, it could improve overall protection even if the immune response is not perfect.

This ease of use may matter a lot for future booster campaigns. Even a highly effective product can fall short if people do not want to receive it. A simple nasal spray could make vaccination feel less intimidating and more routine.

4. Potential for simpler distribution

Some nasal formulations may be easier to administer in certain settings, such as schools, clinics, and mass vaccination campaigns. That could make repeat dosing or boosters more convenient.

Convenience matters because public health tools work best when they are easy to deliver at scale. A spray can reduce dependence on needles, syringes, and some of the staffing challenges that come with injection-based campaigns.

5. More direct immune response at the virus’s entry point

Because respiratory viruses often enter through the nose, local immunity is logically attractive. Experts have long pursued nasal immunization for influenza, RSV, and other respiratory infections for this reason.

COVID-19 is not unique in that regard. It is simply one of the clearest examples of why a local response could matter. If the first immune barrier is where the virus first lands, the defense may be more efficient.

What users often mean by “beat COVID-19 vaccines”

This phrase can be misleading, so it helps to define it clearly.

When people say nasal sprays could beat COVID-19 vaccines, they may mean one of several things:

• better at stopping infection
• better at reducing spread
• more convenient to use
• more acceptable to hesitant groups
• possibly better as a booster strategy
• potentially better at creating mucosal immunity

They do not necessarily mean nasal sprays would replace vaccines as the best defense against severe disease overnight.

In fact, the most likely future scenario is a combination approach: injectable vaccines for strong systemic protection, plus nasal vaccines or sprays for better local protection.

That combination could be especially useful in people at higher risk, including older adults and those with chronic health conditions. It may also be useful in settings where preventing infection is particularly important, such as healthcare facilities and schools.

Are nasal sprays already available for COVID-19?

In many places, not yet on a broad public scale.

Several nasal COVID-19 vaccines have been studied or authorized in some regions, but availability varies widely by country. Some products remain in trials, while others have limited approvals or are not widely distributed.

That means the concept is promising, but the science is still evolving.

Readers who follow vaccine policy often also want to know how availability and public guidance change over time. For broader context on vaccine decision-making, see COVID-19 vaccines for kids: Why Parents Should Book Now, which shows how recommendations can differ depending on age, timing, and public health priorities.

Availability also depends on manufacturing capacity, regulatory approval, and whether a product is used as a primary vaccine or as a booster. A nasal spray that works well as a booster may not necessarily be positioned as a first-line replacement for existing shots.

What the research has shown so far

Early studies of nasal COVID vaccines have suggested that they may generate local immune responses and, in some cases, reduce viral load or transmission in animal models and human trials.

Still, researchers must answer several important questions before nasal sprays can be widely adopted:

• How long does protection last?
• How strong is the immune response compared with shots?
• How well do they work against new variants?
• Are they safe across different age groups?
• Can they be manufactured at scale?

Because COVID-19 continues to evolve, scientists also need to test whether nasal vaccines remain effective as the virus changes.

That’s why many experts see the current evidence as promising but incomplete. The early data support continued research, but they do not yet justify the idea that nasal sprays have already replaced conventional vaccines in most real-world settings.

For a high-level scientific overview of respiratory-virus vaccine delivery and immune response, the U.S. National Institute of Allergy and Infectious Diseases provides useful background on mucosal immunity and vaccine development at the NIAID official website.

Why COVID variants matter

One of the biggest challenges in COVID-19 prevention is viral mutation.

A nasal vaccine could be valuable if it helps stop infection at the entry point, but it still has to work against circulating variants. If the virus changes too much, protection may weaken.

Experts are therefore studying:

• updated antigen designs
• broader immune targets
• booster strategies
• combination vaccines

This is similar to how flu vaccines are adapted over time.

Variant pressure is part of the reason researchers are looking at broader immune approaches rather than narrowly focused formulas. If a vaccine can trigger protection in the nose and also stimulate a more durable response throughout the body, it may be more resilient when the virus changes.

Could nasal sprays replace COVID vaccines?

For most people, probably not in the near future.

The more realistic expectation is that nasal sprays may complement existing vaccines rather than replace them.

Why?

Because injectable vaccines currently have a strong track record for preventing severe disease. Nasal vaccines may add a layer of protection that is especially useful for:

• preventing infection
• reducing transmission
• improving public acceptance
• adding convenience

In other words, the best future strategy may involve using both types of immunity: systemic and mucosal.

This also fits the way many experts think about respiratory disease more broadly. One tool may not do everything. But a layered strategy can provide better overall protection than relying on a single mechanism.

Common questions about nasal COVID sprays

Are nasal sprays safer than vaccines?

Not automatically. Safety depends on the product, ingredients, and how it is designed. Some nasal vaccines may be very safe, but they still require testing and regulatory review like any other medical product.

Do nasal sprays work without injections?

Yes, that is the goal. Nasal vaccines are designed to be administered through the nose and trigger immunity without a shot.

Will a nasal spray stop all COVID infections?

Probably not all infections. The goal is to reduce the risk of infection, lower viral load, and prevent serious disease. No vaccine is perfect, and respiratory viruses are difficult to block completely.

Are nasal vaccines better for children?

They may be more acceptable to children because they avoid needles, but effectiveness and age-specific safety must be proven first.

If I’m vaccinated already, do I still need a nasal spray later?

Possibly, if future guidance recommends it as a booster or added protection. That depends on how products are approved and how well they perform over time.

For parents who are thinking about infection symptoms and when to seek medical advice, it may also be useful to read Bloody Nose and COVID: What It Means & When to Worry, since nasal symptoms can be confusing during respiratory infections.

The biggest advantages in plain language

If you want the simplest explanation, here it is:

• Current COVID vaccines are great at preventing severe illness.
• Nasal Sprays may be better at stopping the virus where it enters.
• That could mean fewer infections and less spread.
• They may also be easier for some people to use.

So experts are interested because nasal sprays could solve a problem that injections do not fully address: strong protection in the nose and throat.

There is also a behavioral advantage. People who dislike needles may avoid vaccination entirely, even when they understand the benefits. A spray could remove a major barrier and improve uptake. In public health terms, that may matter as much as the biology itself.

The biggest limitations

Despite the optimism, there are real hurdles.

1. Long-term effectiveness is uncertain

Some nasal vaccines may not last as long as injectable vaccines, or they may need boosters.

2. Variant coverage is a challenge

The virus keeps changing, and nasal vaccines must keep up.

3. Manufacturing and approval take time

Even promising products need large-scale studies and regulatory review.

4. Public trust matters

A new type of vaccine needs clear communication so people understand what it does and does not do.

5. Real-world performance may differ from theory

Many medical ideas look strong in early studies but deliver more modest results once they are tested broadly. That is why large human trials and real-world data are essential before making big claims.

There is also the issue of dosage and delivery consistency. A spray must reach the right tissue, in the right amount, and in a way that reliably produces the intended immune response. That sounds simple, but in practice it is one of the hardest parts of vaccine design.

What this means for you right now

If you are trying to decide what to do today, the key point is simple: COVID-19 vaccines are still the main proven tool for reducing severe disease and death.

Nasal Sprays are an exciting area of research because they may one day offer:

• better prevention of infection
• improved control of spread
• needle-free administration

But they are best viewed as a developing addition to COVID-19 prevention, not a replacement for current vaccines at this time.

If you are following broader public health debates, you may also notice that vaccine design and vaccine policy keep evolving together. Some articles discuss incentives, mandates, and age-specific guidance because the best prevention strategy depends not just on science, but on how the public actually receives it. A related example is COVID-19 vaccine mandates: Why Employers Want to Make COVID-19 Vaccines Mandatory, which shows how policy can shape vaccine uptake and expectations.

For now, the practical takeaway is to stay informed, follow current medical guidance, and view nasal vaccines as a promising future option rather than a current replacement.

Bottom line

Experts say nasal sprays could “beat” COVID-19 vaccines because they may provide better protection in the nose and upper airway, where the virus first enters the body. That could make them more effective at preventing infection and transmission than standard shots alone.

However, traditional COVID-19 vaccines still play a crucial role by strongly reducing severe illness, hospitalization, and death. The most likely future is not nasal sprays versus vaccines, but a combination of both—using each for the kind of protection it does best.

Nasal Sprays are promising because they may finally help close the gap between protecting the body from serious disease and stopping the virus before it spreads.